Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients

Surgery remains the best treatment for obtaining cure in patients with resectable lung cancer, regardless of age. In elderly patients, however, the presumed fear of decreased performance status (PS) after lobectomy has resulted in the delivery of sub-optimal cancer surgery. Surgical decision making...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic disease 2017-06, Vol.9 (6), p.1525-1530
Hauptverfasser: Kawaguchi, Yo, Hanaoka, Jun, Oshio, Yasuhiko, Hashimoto, Masayuki, Igarashi, Tomoyuki, Kataoka, Yoko, Kaku, Ryosuke, Namura, Yuki, Akazawa, Akira
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1530
container_issue 6
container_start_page 1525
container_title Journal of thoracic disease
container_volume 9
creator Kawaguchi, Yo
Hanaoka, Jun
Oshio, Yasuhiko
Hashimoto, Masayuki
Igarashi, Tomoyuki
Kataoka, Yoko
Kaku, Ryosuke
Namura, Yuki
Akazawa, Akira
description Surgery remains the best treatment for obtaining cure in patients with resectable lung cancer, regardless of age. In elderly patients, however, the presumed fear of decreased performance status (PS) after lobectomy has resulted in the delivery of sub-optimal cancer surgery. Surgical decision making for such patients would become easier if post-lobectomy survival benefits and changes in PS were well defined. We reviewed patients aged 75 years or older who received lobectomy for non-small cell lung cancer (NSCLC) at our hospital between January 2004 and December 2014. Eastern Cooperative Oncology Group PS was preoperatively and postoperatively assessed in 137 patients. Patients were classified into 2 groups based on the change in PS: in Group 1, postoperative and preoperative PS were the same; in group 2, postoperative PS was less than preoperative PS. We compared the characteristics of patients in groups 1 and 2. Overall 5-year survival was 47.4% in group 1 and 0% in group 2 (P
doi_str_mv 10.21037/jtd.2017.04.37
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5506121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1923113066</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-9c6838a455e2ca23326d1b73324d04d303a8af42dff7b732ad9ad70edd8856733</originalsourceid><addsrcrecordid>eNpVkc1rGzEQxUVoiUPqc29Fx1zW0ddKu5dCcPNRMPTSnsVYmnU37K5cSVvwf185Tkyjy4jRb94b9Aj5zNlKcCbN7XP2K8G4WTG1kuaCXAlmTKW1UB9e7qLiSrYLskzpmZWjmRDGXJKFaIxiWtdXZPsNXURISPuJ7jF2IY4wOaQpQ54ThS5jpEPYosthPNARoXAhRLqPYTeF1KfjJA4e43CgwzztqDsKFAByj1NOn8jHDoaEy9d6TX493P9cP1WbH4_f13ebyslW5qp1upENqLpG4UBIKbTnW1Oq8kx5ySQ00Cnhu86UtgDfgjcMvW-aWhfumnw96e7n7YjeFe8Ig93HfoR4sAF6-_5l6n_bXfhr65ppLngRuHkViOHPjCnbsU8OhwEmDHOyvBWSc1k-rqC3J9TFkFLE7mzDmX0Jx5Zw7DEcy5SVpkx8-X-7M_8WhfwHwzSNMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1923113066</pqid></control><display><type>article</type><title>Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kawaguchi, Yo ; Hanaoka, Jun ; Oshio, Yasuhiko ; Hashimoto, Masayuki ; Igarashi, Tomoyuki ; Kataoka, Yoko ; Kaku, Ryosuke ; Namura, Yuki ; Akazawa, Akira</creator><creatorcontrib>Kawaguchi, Yo ; Hanaoka, Jun ; Oshio, Yasuhiko ; Hashimoto, Masayuki ; Igarashi, Tomoyuki ; Kataoka, Yoko ; Kaku, Ryosuke ; Namura, Yuki ; Akazawa, Akira</creatorcontrib><description>Surgery remains the best treatment for obtaining cure in patients with resectable lung cancer, regardless of age. In elderly patients, however, the presumed fear of decreased performance status (PS) after lobectomy has resulted in the delivery of sub-optimal cancer surgery. Surgical decision making for such patients would become easier if post-lobectomy survival benefits and changes in PS were well defined. We reviewed patients aged 75 years or older who received lobectomy for non-small cell lung cancer (NSCLC) at our hospital between January 2004 and December 2014. Eastern Cooperative Oncology Group PS was preoperatively and postoperatively assessed in 137 patients. Patients were classified into 2 groups based on the change in PS: in Group 1, postoperative and preoperative PS were the same; in group 2, postoperative PS was less than preoperative PS. We compared the characteristics of patients in groups 1 and 2. Overall 5-year survival was 47.4% in group 1 and 0% in group 2 (P&lt;0.001). History of cardiac ischemia (P=0.001) and squamous cell carcinoma (P=0.015) were identified as significant predictors of reduced postoperative PS. Our results show that maintenance of PS after lobectomy is expected to be associated with a good prognosis. However, reduction of PS after lobectomy indicates an extremely poor prognosis in elderly patients with lung cancer. History of cardiac ischemia and squamous cell carcinoma are possible risk factors for decreasing PS. Thus, careful patient evaluation and selection are needed when deciding whether to use lobectomy in clinical practice.</description><identifier>ISSN: 2072-1439</identifier><identifier>EISSN: 2077-6624</identifier><identifier>DOI: 10.21037/jtd.2017.04.37</identifier><identifier>PMID: 28740665</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Original</subject><ispartof>Journal of thoracic disease, 2017-06, Vol.9 (6), p.1525-1530</ispartof><rights>2017 Journal of Thoracic Disease. All rights reserved. 2017 Journal of Thoracic Disease.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-9c6838a455e2ca23326d1b73324d04d303a8af42dff7b732ad9ad70edd8856733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506121/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506121/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28740665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawaguchi, Yo</creatorcontrib><creatorcontrib>Hanaoka, Jun</creatorcontrib><creatorcontrib>Oshio, Yasuhiko</creatorcontrib><creatorcontrib>Hashimoto, Masayuki</creatorcontrib><creatorcontrib>Igarashi, Tomoyuki</creatorcontrib><creatorcontrib>Kataoka, Yoko</creatorcontrib><creatorcontrib>Kaku, Ryosuke</creatorcontrib><creatorcontrib>Namura, Yuki</creatorcontrib><creatorcontrib>Akazawa, Akira</creatorcontrib><title>Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients</title><title>Journal of thoracic disease</title><addtitle>J Thorac Dis</addtitle><description>Surgery remains the best treatment for obtaining cure in patients with resectable lung cancer, regardless of age. In elderly patients, however, the presumed fear of decreased performance status (PS) after lobectomy has resulted in the delivery of sub-optimal cancer surgery. Surgical decision making for such patients would become easier if post-lobectomy survival benefits and changes in PS were well defined. We reviewed patients aged 75 years or older who received lobectomy for non-small cell lung cancer (NSCLC) at our hospital between January 2004 and December 2014. Eastern Cooperative Oncology Group PS was preoperatively and postoperatively assessed in 137 patients. Patients were classified into 2 groups based on the change in PS: in Group 1, postoperative and preoperative PS were the same; in group 2, postoperative PS was less than preoperative PS. We compared the characteristics of patients in groups 1 and 2. Overall 5-year survival was 47.4% in group 1 and 0% in group 2 (P&lt;0.001). History of cardiac ischemia (P=0.001) and squamous cell carcinoma (P=0.015) were identified as significant predictors of reduced postoperative PS. Our results show that maintenance of PS after lobectomy is expected to be associated with a good prognosis. However, reduction of PS after lobectomy indicates an extremely poor prognosis in elderly patients with lung cancer. History of cardiac ischemia and squamous cell carcinoma are possible risk factors for decreasing PS. Thus, careful patient evaluation and selection are needed when deciding whether to use lobectomy in clinical practice.</description><subject>Original</subject><issn>2072-1439</issn><issn>2077-6624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkc1rGzEQxUVoiUPqc29Fx1zW0ddKu5dCcPNRMPTSnsVYmnU37K5cSVvwf185Tkyjy4jRb94b9Aj5zNlKcCbN7XP2K8G4WTG1kuaCXAlmTKW1UB9e7qLiSrYLskzpmZWjmRDGXJKFaIxiWtdXZPsNXURISPuJ7jF2IY4wOaQpQ54ThS5jpEPYosthPNARoXAhRLqPYTeF1KfjJA4e43CgwzztqDsKFAByj1NOn8jHDoaEy9d6TX493P9cP1WbH4_f13ebyslW5qp1upENqLpG4UBIKbTnW1Oq8kx5ySQ00Cnhu86UtgDfgjcMvW-aWhfumnw96e7n7YjeFe8Ig93HfoR4sAF6-_5l6n_bXfhr65ppLngRuHkViOHPjCnbsU8OhwEmDHOyvBWSc1k-rqC3J9TFkFLE7mzDmX0Jx5Zw7DEcy5SVpkx8-X-7M_8WhfwHwzSNMw</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Kawaguchi, Yo</creator><creator>Hanaoka, Jun</creator><creator>Oshio, Yasuhiko</creator><creator>Hashimoto, Masayuki</creator><creator>Igarashi, Tomoyuki</creator><creator>Kataoka, Yoko</creator><creator>Kaku, Ryosuke</creator><creator>Namura, Yuki</creator><creator>Akazawa, Akira</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201706</creationdate><title>Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients</title><author>Kawaguchi, Yo ; Hanaoka, Jun ; Oshio, Yasuhiko ; Hashimoto, Masayuki ; Igarashi, Tomoyuki ; Kataoka, Yoko ; Kaku, Ryosuke ; Namura, Yuki ; Akazawa, Akira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-9c6838a455e2ca23326d1b73324d04d303a8af42dff7b732ad9ad70edd8856733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Kawaguchi, Yo</creatorcontrib><creatorcontrib>Hanaoka, Jun</creatorcontrib><creatorcontrib>Oshio, Yasuhiko</creatorcontrib><creatorcontrib>Hashimoto, Masayuki</creatorcontrib><creatorcontrib>Igarashi, Tomoyuki</creatorcontrib><creatorcontrib>Kataoka, Yoko</creatorcontrib><creatorcontrib>Kaku, Ryosuke</creatorcontrib><creatorcontrib>Namura, Yuki</creatorcontrib><creatorcontrib>Akazawa, Akira</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thoracic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawaguchi, Yo</au><au>Hanaoka, Jun</au><au>Oshio, Yasuhiko</au><au>Hashimoto, Masayuki</au><au>Igarashi, Tomoyuki</au><au>Kataoka, Yoko</au><au>Kaku, Ryosuke</au><au>Namura, Yuki</au><au>Akazawa, Akira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients</atitle><jtitle>Journal of thoracic disease</jtitle><addtitle>J Thorac Dis</addtitle><date>2017-06</date><risdate>2017</risdate><volume>9</volume><issue>6</issue><spage>1525</spage><epage>1530</epage><pages>1525-1530</pages><issn>2072-1439</issn><eissn>2077-6624</eissn><abstract>Surgery remains the best treatment for obtaining cure in patients with resectable lung cancer, regardless of age. In elderly patients, however, the presumed fear of decreased performance status (PS) after lobectomy has resulted in the delivery of sub-optimal cancer surgery. Surgical decision making for such patients would become easier if post-lobectomy survival benefits and changes in PS were well defined. We reviewed patients aged 75 years or older who received lobectomy for non-small cell lung cancer (NSCLC) at our hospital between January 2004 and December 2014. Eastern Cooperative Oncology Group PS was preoperatively and postoperatively assessed in 137 patients. Patients were classified into 2 groups based on the change in PS: in Group 1, postoperative and preoperative PS were the same; in group 2, postoperative PS was less than preoperative PS. We compared the characteristics of patients in groups 1 and 2. Overall 5-year survival was 47.4% in group 1 and 0% in group 2 (P&lt;0.001). History of cardiac ischemia (P=0.001) and squamous cell carcinoma (P=0.015) were identified as significant predictors of reduced postoperative PS. Our results show that maintenance of PS after lobectomy is expected to be associated with a good prognosis. However, reduction of PS after lobectomy indicates an extremely poor prognosis in elderly patients with lung cancer. History of cardiac ischemia and squamous cell carcinoma are possible risk factors for decreasing PS. Thus, careful patient evaluation and selection are needed when deciding whether to use lobectomy in clinical practice.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>28740665</pmid><doi>10.21037/jtd.2017.04.37</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-1439
ispartof Journal of thoracic disease, 2017-06, Vol.9 (6), p.1525-1530
issn 2072-1439
2077-6624
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5506121
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Original
title Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A48%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20performance%20status%20after%20lobectomy%20mean%20poor%20prognosis%20in%20elderly%20lung%20cancer%20patients&rft.jtitle=Journal%20of%20thoracic%20disease&rft.au=Kawaguchi,%20Yo&rft.date=2017-06&rft.volume=9&rft.issue=6&rft.spage=1525&rft.epage=1530&rft.pages=1525-1530&rft.issn=2072-1439&rft.eissn=2077-6624&rft_id=info:doi/10.21037/jtd.2017.04.37&rft_dat=%3Cproquest_pubme%3E1923113066%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1923113066&rft_id=info:pmid/28740665&rfr_iscdi=true